Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (80 ops.)
Latest filing published 15 Sept 2026 for Korro Bio, Inc., €102k.
Filing timeline
BuySaleJean Francois Formela
Insider track record
Disclosed buys
2
Disclosed sells
80
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jean Francois Formela: trading record in brief
Filings by Jean Francois Formela span 5 companies, the busiest being Intellia Therapeutics, Inc., Korro Bio, Inc. and Translate Bio, Inc. In total, 100 filings cover trades dated from 11 May 2016 to 14 September 2026.
The open-market side counts 2 purchases for €6.9M alongside 80 sales for €204.2M. Netting one side against the other leaves €197.4M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants. Since January 2026: no purchases and 24 sales on the market.
The latest filing, published on 15 September 2026, reports an open-market sale of €102k in Korro Bio, Inc. The most recent open-market purchase was published on 14 December 2021, 1,775 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jean Francois Formela
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations95 total
8,450 shares@ US$13.990.087% mcap1.9% of flowCommon StockSEC:0001030575-26-000014:0
1,750 shares@ US$13.990.018% mcap0.4% of flowCommon StockSEC:0001030575-26-000014:1
31,888 shares@ US$14.120.33% mcap7.1% of flowCommon StockSEC:0001030575-26-000014:2
6,602 shares@ US$14.120.069% mcap1.5% of flowCommon StockSEC:0001030575-26-000014:3
249 shares@ US$13.960.0024% mcap0.1% of flowCommon StockSEC:0001030575-26-000012:0
51 shares@ US$13.960.0005% mcap0.0% of flowCommon StockSEC:0001030575-26-000012:1
23,584 shares@ US$14.000.23% mcap8.7% of flowCommon StockSEC:0001030575-26-000010:0
4,884 shares@ US$14.000.048% mcap1.8% of flowCommon StockSEC:0001030575-26-000010:1
1,775 shares@ US$13.960.017% mcap0.7% of flowCommon StockSEC:0001030575-26-000008:0
368 shares@ US$13.960.0036% mcap0.1% of flowCommon StockSEC:0001030575-26-000008:1
85,955 shares@ US$14.030.85% mcap32.1% of flowCommon StockSEC:0001030575-26-000006:0
14,745 shares@ US$14.030.15% mcap5.5% of flowCommon StockSEC:0001030575-26-000006:1
817 shares@ US$13.960.0081% mcap0.3% of flowCommon StockSEC:0001030575-26-000006:2
8,506 shares@ US$13.960.084% mcap3.2% of flowCommon StockSEC:0001030575-26-000006:3
40,679 shares@ US$14.609.6% of flowCommon StockSEC:0001030575-26-000004:4
114 shares@ US$14.980.0% of flowCommon StockSEC:0001030575-26-000004:7
17,426 shares@ US$14.254.0% of flowCommon StockSEC:0001030575-26-000004:3
101,579 shares@ US$14.2523.3% of flowCommon StockSEC:0001030575-26-000004:2
580 shares@ US$13.950.1% of flowCommon StockSEC:0001030575-26-000004:1
666 shares@ US$14.980.2% of flowCommon StockSEC:0001030575-26-000004:5
6,979 shares@ US$14.601.6% of flowCommon StockSEC:0001030575-26-000004:6
3,382 shares@ US$13.950.8% of flowCommon StockSEC:0001030575-26-000004:0
2,441 shares@ US$13.950.9% of flowCommon StockSEC:0001030575-26-000002:0
419 shares@ US$13.950.2% of flowCommon StockSEC:0001030575-26-000002:1
17,857 shares@ US$56.0028.5% of flowCommon StockSEC:0001415889-24-011388:0
25 of 95 declarations
